Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine Response Adaptive Study in HBeAg Positive CHB
NCT00537537Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2007
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Novartis. Started Aug 2007; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00537537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537537.